In an effort to increase knowledge and understanding of the process of assuring data quality and validity in clinical trials, the IOM hosted a workshop to open a dialogue on the process to identify and discuss issues of mutual concern among industry, regulators, payers, and consumers. The presenters and panelists together developed strategies that could be used to address the issues that were identified. This IOM report of the workshop summarizes the present status and highlights possible strategies for making improvements to the education of interested and affected parties as well as facilitating future planning.
Table of Contents
|Presubmission and Submission||13-25|
|FDA Regulatory Review||26-41|
|Summary of Issues||42-42|
|Directions for the Future||43-44|
|Appendix A: Workshop Agenda||51-55|
|Appendix B: Speakers and Panelists||56-58|
|Appendix C: Workshop Registrants||59-67|
|Appendix D: Glossary and Acronyms||68-76|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Assuring Data Quality and Validity in Clinical Trials for Regulatory Decision Making: Workshop Report...